Toshio Sada

1.4k total citations
36 papers, 1.2k citations indexed

About

Toshio Sada is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Toshio Sada has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Toshio Sada's work include Renin-Angiotensin System Studies (12 papers), Hormonal Regulation and Hypertension (7 papers) and Chronic Kidney Disease and Diabetes (5 papers). Toshio Sada is often cited by papers focused on Renin-Angiotensin System Studies (12 papers), Hormonal Regulation and Hypertension (7 papers) and Chronic Kidney Disease and Diabetes (5 papers). Toshio Sada collaborates with scholars based in Japan, United States and Germany. Toshio Sada's co-authors include Makoto Mizuno, Hiroyuki Koike, Hiroyuki Koike, Masahiro Ikeda, Masaaki Miyamoto, Kiyoshi Oizumi, Hiroaki Yanagisawa, Mikio Kato, Hiroshi Nishino and Norio Fukuda and has published in prestigious journals such as Circulation Research, Biochemical and Biophysical Research Communications and Hypertension.

In The Last Decade

Toshio Sada

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toshio Sada Japan	17	553	407	326	208	112	36	1.2k
Mario Campagnola Italy	18	236 0.4×	275 0.7×	515 1.6×	232 1.1×	60 0.5×	24	1.9k
Anna Fratta Pasini Italy	23	430 0.8×	216 0.5×	625 1.9×	354 1.7×	55 0.5×	29	2.2k
Yuki Suzaki Japan	19	558 1.0×	464 1.1×	528 1.6×	153 0.7×	175 1.6×	32	1.5k
John Quilley United States	29	426 0.8×	742 1.8×	400 1.2×	911 4.4×	74 0.7×	67	2.1k
Adebayo Oyekan United States	23	326 0.6×	505 1.2×	407 1.2×	548 2.6×	106 0.9×	87	1.5k
Eduardo Barbosa‐Sicard Germany	21	245 0.4×	576 1.4×	463 1.4×	584 2.8×	45 0.4×	22	2.2k
Mairéad A. Carroll United States	27	328 0.6×	897 2.2×	480 1.5×	670 3.2×	47 0.4×	74	2.4k
Christopher Ho United States	8	452 0.8×	373 0.9×	488 1.5×	294 1.4×	40 0.4×	8	1.2k
Magdalena Alonso‐Galicia United States	26	459 0.8×	870 2.1×	329 1.0×	695 3.3×	101 0.9×	38	1.9k
J. Augustín Germany	19	274 0.5×	316 0.8×	309 0.9×	145 0.7×	38 0.3×	46	1.2k

Countries citing papers authored by Toshio Sada

Since Specialization

Citations

This map shows the geographic impact of Toshio Sada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshio Sada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshio Sada more than expected).

Fields of papers citing papers by Toshio Sada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshio Sada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshio Sada. The network helps show where Toshio Sada may publish in the future.

Co-authorship network of co-authors of Toshio Sada

This figure shows the co-authorship network connecting the top 25 collaborators of Toshio Sada. A scholar is included among the top collaborators of Toshio Sada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshio Sada. Toshio Sada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arai, Kiyoshi, Yuka Morikawa, Naoko Ubukata, et al.. (2015). Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist. European Journal of Pharmacology. 761. 226–234. 112 indexed citations

Kato, Mikio, et al.. (2014). R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model. European Journal of Pharmacology. 734. 60–66. 18 indexed citations

Izuhara, Yuko, Toshio Sada, Hiroaki Yanagisawa, et al.. (2008). A Novel Sartan Derivative With Very Low Angiotensin II Type 1 Receptor Affinity Protects the Kidney in Type 2 Diabetic Rats. Arteriosclerosis Thrombosis and Vascular Biology. 28(10). 1767–1773. 16 indexed citations

Mizuno, Makoto, et al.. (2006). The Effect of Angiotensin II Receptor Blockade on an End-Stage Renal Failure Model of Type 2 Diabetes. Journal of Cardiovascular Pharmacology. 48(4). 135–142. 30 indexed citations

Kato, Mikio, et al.. (2006). Severity of Hyperlipidemia Does Not Affect Antiatherosclerotic Effect of an Angiotensin II Receptor Antagonist in Apolipoprotein E-deficient Mice. Journal of Cardiovascular Pharmacology. 47(6). 764–769. 8 indexed citations

Kato, Mikio, Toshio Sada, Makoto Mizuno, et al.. (2005). Effect of Combined Treatment With an Angiotensin II Receptor Antagonist and an HMG-CoA Reductase Inhibitor on Atherosclerosis in Genetically Hyperlipidemic Rabbits. Journal of Cardiovascular Pharmacology. 46(4). 556–562. 17 indexed citations

Sada, Toshio & Makoto Mizuno. (2004). Pharmacological profiles and clinical effects of olmesartan medoxomil, a novel angiotensin II receptor blocker. Folia Pharmacologica Japonica. 124(4). 257–269. 5 indexed citations

Nangaku, Masaomi, Toshio Miyata, Toshio Sada, et al.. (2003). Anti-Hypertensive Agents Inhibit In Vivo the Formation of Advanced Glycation End Products and Improve Renal Damage in a Type 2 Diabetic Nephropathy Rat Model. Journal of the American Society of Nephrology. 14(5). 1212–1222. 149 indexed citations

Mizuno, Makoto, Toshio Sada, Mikio Kato, & Hiroyuki Koike. (2002). Renoprotective Effects of Blockade of Angiotensin II AT1 Receptors in an Animal Model of Type 2 Diabetes. Hypertension Research. 25(2). 271–278. 66 indexed citations

10.

Michel, Gilles, Nobuhiro Murayama, Toshio Sada, et al.. (2000). Two N-terminally truncated forms of C-type natriuretic peptide from habu snake venom. Peptides. 21(5). 609–615. 12 indexed citations

11.

Kim, Shokei, Toshio Sada, Makoto Mizuno, et al.. (1997). Effects of Angiotensin AT1 Receptor Antagonist on Volume Overload-Induced Cardiac Gene Expression in Rats.. Hypertension Research. 20(2). 133–142. 11 indexed citations

12.

Mizuno, Makoto, Toshio Sada, Masahiro Ikeda, et al.. (1995). Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist. European Journal of Pharmacology. 285(2). 181–188. 134 indexed citations

13.

Yorikane, Ryosuke, Toshio Sada, & Hiroyuki Koike. (1993). Effects of RS-2135, a New Antiarrhythmic Agent, on the Kinetics of Use-Dependent Decrease in Maximum Upstroke Velocity in Guinea Pig Ventricular Myocardium. Journal of Cardiovascular Pharmacology. 21(3). 430–434. 2 indexed citations

14.

Yorikane, Ryosuke, Toshio Sada, & Hiroyuki Koike. (1992). Electrophysiologic Effects of RS-2135, a New Antiarrhythmic Compound, on Canine Purkinje Fibers. Journal of Cardiovascular Pharmacology. 20(6). 955–960. 3 indexed citations

15.

Oizumi, Kiyoshi, Hiroshi Nishino, Hiroshi Shiga, et al.. (1990). Hemodynamic Changes Following Long-Term Administration of CS-905, a Novel Dihydropyridine Calcium Blocker, in Conscious SHR. The Japanese Journal of Pharmacology. 54(1). 1–6. 16 indexed citations

16.

Oizumi, Kiyoshi, Hiroshi Nishino, Hiroyuki Koike, et al.. (1989). Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker.. The Japanese Journal of Pharmacology. 51(1). 57–64. 57 indexed citations

17.

Oizumi, Kiyoshi, Hiroshi Nishino, Hiroyuki Koike, et al.. (1989). Antihypertensive Effects of CS-905, a Novel Dihydropyridine Ca++ Channel Blocker. The Japanese Journal of Pharmacology. 51(1). 57–64. 16 indexed citations

18.

Sada, Toshio, Haruki Koike, & M Miyamoto. (1989). Long-term inhibition of angiotensin converting enzyme suppresses calcium channel agonist-induced contraction of aorta in hypertensive rats.. Hypertension. 14(6). 652–659. 25 indexed citations

19.

Oizumi, Kiyoshi, Hiroyuki Koike, Toshio Sada, et al.. (1988). Pharmacological Profiles of CS-622, a Novel Angiotensin Converting Enzyme Inhibitor. The Japanese Journal of Pharmacology. 48(3). 349–356. 36 indexed citations

20.

Oda, Tomiichiro, et al.. (1988). Effects of chronic treatment with a novel angiotensin converting enzyme inhibitor, CS622, and a vasodilator, hydralazine, on atrial natriuretic factor (ANF) in spontaneously hypertensive rats (SHR). Biochemical and Biophysical Research Communications. 152(1). 456–462. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact